Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Get Free Report) CAO Jonathan David Lanoy sold 4,000 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $24.70, for a total transaction of $98,800.00. Following the completion of the transaction, the chief accounting officer directly owned 46,405 shares of the company’s stock, valued at $1,146,203.50. This trade represents a 7.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Nature’s Sunshine Products Price Performance
NASDAQ NATR traded up $0.09 during midday trading on Monday, hitting $24.58. 115,667 shares of the company traded hands, compared to its average volume of 129,684. The company has a market cap of $430.31 million, a PE ratio of 23.18 and a beta of 0.93. The company’s 50-day simple moving average is $25.10 and its 200-day simple moving average is $20.51. Nature’s Sunshine Products, Inc. has a 52 week low of $11.01 and a 52 week high of $28.14.
Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) last released its quarterly earnings results on Tuesday, March 10th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.19 by $0.11. The firm had revenue of $123.81 million during the quarter, compared to analyst estimates of $121.62 million. Nature’s Sunshine Products had a return on equity of 14.36% and a net margin of 4.07%.
Institutional Inflows and Outflows
Analysts Set New Price Targets
A number of equities analysts have commented on NATR shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Nature’s Sunshine Products in a report on Monday, December 29th. Canaccord Genuity Group lifted their price objective on shares of Nature’s Sunshine Products from $22.00 to $29.00 and gave the stock a “buy” rating in a research report on Tuesday, March 10th. Finally, DA Davidson boosted their price objective on shares of Nature’s Sunshine Products from $23.00 to $33.00 and gave the stock a “buy” rating in a research note on Thursday. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, Nature’s Sunshine Products currently has a consensus rating of “Moderate Buy” and a consensus target price of $31.00.
Get Our Latest Report on Nature’s Sunshine Products
About Nature’s Sunshine Products
Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.
The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.
Read More
- Five stocks we like better than Nature’s Sunshine Products
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- I tried out Elon Musk’s new AI tech — it floored me
- Iran isn’t the real war
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
